14.11.2011 • News

AkzoNobel, Fluorchemie Create CF Carbons JV

AkzoNobel Industrial Chemicals and Fluorchemie have announced the establishment of joint venture called CF Carbons GmbH. The JV will be used for the production, marketing and sales of the fluorocarbon HCFC22 (R22) in Frankfurt, Germany. Financial details were not disclosed.

The 50/50 joint venture of CF Carbons which will be effective as of Jan. 1, will formalize an existing relationship and will provide long term stability to AkzoNobel, Fluorchemie and the customers of R22. AkzoNobel brings to the joint venture its knowhow about chlorine production, whereas Fluorchemie brings the production assets and its fluorine knowledge. The R22 plant has a production capacity of 24 kt/year.

Chloroform and HF are the main raw materials for the production of R 22. R22 is the most important feedstock for fluoropolymers particularly for PTFE. Demand for PTFE grows by 4%/year in a wide spectrum of applications, due to superior product properties. Future potential for R22 lies in a newly developed refrigerant based on R22 and on other chlorinated fluorocarbons as a substitute for automotive air-conditioning systems.

The R22 activities are currently owned by Fluorchemie. The Fluorchemie Group is one of the biggest European producers of HF and is backward integrated in fluorspar mining.

The joint venture will have its operation in Frankfurt am Main, where AkzoNobel is investing €140 million to convert its chlorine plant in Frankfurt to state-of-the-art membrane electrolysis technology.  

 

 

Company

Logo:

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.